Summary

For heart failure patients who are undergoing cardiac resynchronization therapy, echocardiographic- or ECG-based optimized AV delay does not improve upon standard programming approaches, according to new findings from the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy [SMART-AV] trial.